REXAHN PHARMACEUTICALS INC - COM (RNN)

CUSIP: 761640101

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / COM
Total 13F shares
7,543,526
Share change
-4,419,435
Total reported value
$6,562,050
Price per share
$0.87
Number of holders
33
Value change
-$4,889,221
Number of buys
18
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 761640101?
CUSIP 761640101 identifies RNN - REXAHN PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REXAHN PHARMACEUTICALS INC - COM (RNN) as of Q2 2014

As of 30 Jun 2014, REXAHN PHARMACEUTICALS INC - COM (RNN) was held by 33 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,543,526 shares. The largest 10 holders included VANGUARD GROUP INC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, AQR CAPITAL MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, WELLS FARGO & COMPANY/MN, Northeast Financial Consultants Inc, Bank of New York Mellon Corp, and CONDOR CAPITAL MANAGEMENT. This page lists 33 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.